As part of the James Cowper Kreston, Passion for Ideas series, we meet Dr Steve Gardner, Co-Founder of PrecisionLife, the company using big data to identify why some drug therapies are more effective on patients than others.
Dr Gardner tells us how their technology can help predict whether a patient is more likely to be severely affected by a disease (or indeed the Covid-19 virus) than others. We also hear how the company has seen significant global expansion, was built to scale from the start and he gives 3 useful tips for business founders.
Bristol engineering design consultants Hydrock has been acquired by Stantec. Hydrock has over 950 employees…
Plans from waterside developers Peel Waters to build a new business campus at Chatham Docks…
Europa Road has signed a contract with DPD Netherlands to run new daily line hauls…
Pure Human Resources, an HR, recruitment and training consultancy based in North Baddesley, Hampshire, is…
The Science Based Targets initiative (SBTi) has approved the near-team emissions reduction targets of medical…
Bagshot-based real estate investor and developer Sixpenny Group has acquired a 45,000 sq ft residential-led…